RIGL
Rigel Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$48.67
+0.35%Forward multiples
Based on analyst estimates
- P/E forward
- 14.47x
- P/E 2026E
- 14.20x
- P/E 2027E
- 10.63x
- P/E 2028E
- 8.30x
- P/S forward
- 2.73x
Trailing multiples
Trailing twelve months
- P/E TTM
- 2.75x
- PEG TTM
- —
- Price / book
- 2.14x
- Price / sales
- 3.28x
- Price / cash flow
- 11.45x
Enterprise value
- Enterprise value
- $853.8M
- EV / sales
- 3.08x
- EV / EBITDA
- 9.08x
- EV / EBIT
- 9.81x
- Market cap
- $909.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026